Showing results (591-600 of 719) with videos related to
Sort By:
Pageof 72
The Journal of Experimental Medicine|July 24, 2013
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell responseMarc Martínez-Llordella, Jonathan H Esensten, Samantha L Bailey-Bucktrout, et al.Neuromolecular Medicine|November 14, 2007
Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in miceFrank Haberman, Sung-Chun Tang, Thiruma V Arumugam, et al.Journal of Cachexia, Sarcopenia and Muscle|June 9, 2025
Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body MyositisGeert M de Vries, Bob Asselbergh, Alice Monticelli, et al.Current Alzheimer Research|September 14, 2019
A Pilot Study of Exenatide Actions in Alzheimer's DiseaseRoger J Mullins, Maja Mustapic, Chee W Chia, et al.Experimental Neurology|July 1, 2008
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenalSung-Chun Tang, Justin D Lathia, Pradeep K Selvaraj, et al.Journal of Alzheimer'S Disease : JAD|September 18, 2010
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's diseaseDong Liu, Michael Pitta, Jong-Hwan Lee, et al.Journal of Neurochemistry|March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.Vaccine|January 18, 2012
DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's diseasePurevdorj B Olkhanud, Mohammed Mughal, Koichi Ayukawa, et al.Neurobiology of Aging|November 16, 2018
Image-guided phenotyping of ovariectomized mice: altered functional connectivity, cognition, myelination, and dopaminergic functionalityCynthia Anckaerts, Jaana van Gastel, Valerie Leysen, et al.Neuromolecular Medicine|April 1, 2003
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine developmentAvindra Nath, Elizabeth Hall, Marnia Tuzova, et al.Pageof 72